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Introduction 
Epidermal growth factor (EGF) is a member of an 
extensive class of molecules, reffered to as growth 
factors,  that  intervenes  in  cell  growth  and 
differentiation.
1 Epidermal  growth  factor  (EGF),  a 
small  polypeptide  consist  of  53  amino  acids  with 
molecular  weight  of  about  6.3kDa,  is  present  in 
copious mammalian species
2-5 There are six cysteine 
residues in the hEGF sequence that comprised three 
disulfide band.
6 Human EGF was purified from urine 
by Cohen & Carpenter, Starkey et al. EFG was first 
isolated  from  the  parotid  gland  of  male  mice  and 
subsequently  from  human  urine  as  urogastrone.
7 
Mouse  EGF  is  derived  from  a  1217  amino  acid 
precursor protein which contains 7 additional EGF-
like  domains.  Human  EGF  is  come  apart  from  a 
1207  amino  acid  precursor.
8  Studies  have 
demonstrated that EGF can prompt abundant effect 
on  both  cells  and  epithelial  tissue.  Besides,  hEGF 
has  been  noticed  to  have  many  biological  actions 
both in vivo and in vitro. Studies have focused on 
the proliferative efficiency of EGF on keratinocytes, 
fibroblasts and epithelial cells.
9,10 The yeast Pichia 
pastoris is a practical system for the expression of 
milligram-to-gram  amounts  of  proteins  for  both 
simple laboratory experimentation and industrialized 
production.
11,12  The  aim  of  this  study  was 
construction of recombinant pPIC9/hEGF which will 
be used for expression of recombinant hEGF in the 
following studies. 
 
Materials and Methods 
Materials 
All  restriction  endonucleases,  T4  DNA  ligase, 
Plasmid Miniprep Kit and Gel Extraction Kit were 
purchased  from  fermentas  company  (Vilnius, 
Lithuania).  EGF  cDNA  was  purchased  from 
genecopoeia  company  (Accession:  NM_001963.2). 
Plasmid pPIC9 which contains AOX1 prompter and 
E. coli strain DH5-ʱ (F– ʦ80lacZΔM15 Δ (lacZYA-
argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA 
supE44 λ– thi-1 gyrA96 relA1) were provided from 
Pasteur Institute of Iran (Tehran). LB medium was 
purchased from Sigma Aldrich (L7658-1KG). 
 
Amplification of hEGF gene with PCR 
Amplification of EFG gene was accomplished by the 
following  primers:  Forward  primer 
5´ATCTGGAGAAAAGAGAGGCTGAAGCTAAT
AGTGACTCTCAATGTCCC3´  and  reverse  primer 
5´AATGAATTCTTAGCGCAGTTCCCACCACTTC
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EGF  cDNA  was  purchased  from  Genecopoeia  Company  and  used  for  PCR 
amplification. Prior to ligation, the PCR product and pPIC9 vector was digested with 
EcoRI and XhoI and ligated in pPIC9 vector and subjected to colony PCR screening and 
sequencing  analysis.  Results:  PCR  amplification  of  EGF  cDNA  using  recombinant 
hEGF-pPIC9  vector  as  template  was  concluded  in  amplification  of  197bp  fragment. 
Construction  of  recombinant  hEGF-pPIC9  of  EGf  gene  was  verified  by  PCR  and 
sequencing. Conclusion: Construction of Recombinant hEGF-pPIC9 was the primary 
stage for production and expression of EFG in the future study.  
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AGGTCTC3´ that contain restriction sites for XhoI 
and EcoRI at 5´terminal respectively (underlined).  
PCR  reaction  contain  10  x  PCR  buffer,  400  µM 
dNTPs,  50  ng  Genomic  DNA,  primers  (EGF-F, 
EGF-R) 0.2 µM from each primer, 3 mM MgCl2 and 
1  unit  from  Taq  DNA  polymerase  (cinnagen)  and 
following  program  was  accomplished  for 
amplification  of  desired  fragment:  Initial 
denaturation at 94 °C for 5 minute followed with 94 °C 
for 1 minute, 52 °C for 20 second for annealing and 
72 °C for 45 second for extention that repeated for 
35 cycles. 
 
Constructing  of  recombinant  vector  and 
sequencing 
The PCR product was purified with GeneJET PCR 
Purification Kit (Fermentas) and digested by EcoRI 
and  XhoI  restriction  enzymes.  Then  this  fragment 
with  pPIC9  vector  that  previously  digested  by 
mentioned  enzymes  subjected  to  ligation  reaction 
and its product was transformed to DH5-ʱ by heat 
shock  method.Various  clone  screened  by  colony 
PCR  method  and  the  positive  clones  analyzed  by 
sequencing using EGF-F primer. 
 
Results 
Amplification of EGF gene 
For this purpose thermal gradient PCR (50-54) was 
carried  out  to  optimized  temperature  of  primer 
annealing.  As  seen  in  Figure  1,  PCR  in  annealing 
temperature  over  than  52  °C  give  rise  to  specific 
amplification of 197bp fragment. (Figure 1) 
 
 
Figure 1. Optimization of PCR reaction for amplification of 
EGF  gene.PCR  in  annealing  temperature  in  52  °C  gives 
rise to specific amplification of 197bp fragment. 
 
Cloning and sequencing of EGF gene 
The double-digested PCR products were mixed with 
predigested pPIC9 vector (Figure 2) and introduced 
in  ligation  reaction.  Then  ligation  product  was 
transformed  to  DH5-ʱ  E.coli  bacteria  and 
recombinant plasmid extracted. The colony PCR was 
carried  out  on  transformant  using  the  mentioned 
primers  and  desired  197bp  fragment  was  observed 
on 1% Agarose by UV transilluminator (Figure 3). In 
the next step, recombinant pPIC9 was analyzed by 
sequencing.  Comparison  of  hEGF  sequence  with 
available  sequences  in  Gene  bank  showed  that 
obtained sequence has 100% homology with Homo 
sapiens epidermal growth factor (hEGF), transcript 
variant 3 ( NM_001178131.1). 
 
 
Figure 2. Digestion of pPIC9 vector: line 1; undigested pPIC9 
vector line 2 and 3; digested pPIC9 vector line 4; DNA ladder 
(1kb). 
 
 
Figure 3. PCR assay for detection of desired 197bp fragment 
in recombinant pPIC9/hEGF vector: line 1; no DNA line 2; EGF 
gene (197bp) line 3; DNA ladder (100bp).  
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Discussion 
The  application  of  P.pastoris  for  the  production  of 
heterologous proteins is highly successful
13 Essential to 
the production of heterologous proteins in P.pastoris is 
construction of expression vector. This necessitates the 
selection of both proper expression vector and related 
strain.
14-16  In  the  present  study  recombinant 
pPIC9/hEGF was  constructed. This  expression  vector 
rely  on  the  AOX1  promoter  and  contains  ʱ-mating 
factor  secretion  signal  for  secretion  of  recombinant 
protein  into  extracellular  environment.
17  A  more 
superiority of Pichia is that it is remarkably suitable for 
fermentation and can reach high cell densities that may 
improve overall protein yields.
13,18,19 Also pichia has a 
secretory system that enable to secrete desired protein 
and  conformation  of  disulfide  bind  was  performed 
easily.
20 For soluble secretory proteins, undoubtedly, it 
is the most simple and the most trustworthy expression 
system  with  possible  to  yield  grams  of  the  favorite 
protein.
21,22 
The  construction  of  recombinant  hEGF  has  been 
conducted by many researchers in a variety of vector 
for  many  applications.
23,24  In  construction  of 
pPIC9/hEGF,  the  important  point  which  should  be 
considered is insertion of correct ORF of gene. At this 
stage of this research, the correction of insert ORF was 
confirmed  by  PCR  and  sequencing  analysis.  In  the 
future  study,  the  construction  of  recombinant  vector 
pPIC9/hEGF  should  be  more  characterized  for 
expression of recombinant protein. 
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